Johnson & Johnson has recalled lots of its Simponi injections for possible substandard dosage of its arthritis treatment, according to a Reuters news report. A Johnson & Johnson spokesperson said ...
Golimumab 50mg/4mL; soln for IV infusion after dilution; preservative- and latex-free. Simponi Aria (golimumab) Injection is a colorless to light yellow solution available in packs of 1 vial. Each ...
Johnson & Johnson's Simponi gains FDA approval for treating pediatric ulcerative colitis, expanding options for young patients with this chronic condition. “Ulcerative colitis is a complex, lifelong ...
The US Food and Drug Administration (FDA) has approved Janssen Biotech, Inc.'s Simponi (golimumab) for the treatment of moderately to severely active ulcerative colitis (UC) in adult patients who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback